Condella Sarah 4

What Happened

• Sarah Condella, Executive Vice President, Human Resources at Exact Sciences (EXAS), was granted 23,224 restricted stock units (RSUs) on February 25, 2026. The award is reported as a derivative acquisition at $0 per share (common for compensation grants) and does not reflect a cash purchase or market sale.

Key Details

• Transaction date: February 25, 2026; Form 4 filed February 27, 2026.
• Transaction type/code: A — Award/Grant (derivative securities: RSUs).
• Grant amount: 23,224 RSUs; reported acquisition price $0.
• Shares of Common Stock reported on Form 4 after the transaction: 135,489 shares.
• Additional holdings (footnote): an aggregate 75,143 vested and unvested options and RSUs (each RSU = contingent right to one share).
• Vesting: these RSUs vest in four equal annual installments beginning February 25, 2027 (per footnote).
• Filing timeliness: Form 4 was filed two days after the transaction date (Feb 27 filing for Feb 25 transaction), which is consistent with the standard two-business-day reporting window.

Context

• These are restricted stock units (derivative awards) that represent a contingent right to receive shares upon vesting — they are compensation, not an open-market purchase or sale. Such grants are routine for executives and provide future equity subject to vesting; they do not indicate an immediate buy or sell of company stock.